Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Pseudoephrine

Pseudoephrine molecule structurePseudoephrine molecule structure
Chemical Class

Pseudoephedrine is used as a nasal decongestant1 and is an isomer of ephedrine.2 At higher doses, it may produce stimulant, appetite-suppressing, and performance-enhancing effects, although recreational effects are reportedly limited. It occurs naturally in ephedra,2 was first isolated in 18891, and was synthesized in the 1920s3. It can increase heart rate and blood pressure,4 with some people more sensitive to these effects.4 Rarely, it is associated with heart attack and hemorrhagic stroke.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~30 mg
Light30-60 mg
Moderate60-90 mg
Strong90-120 mg
Heavy120+ mg

Duration

Onset10-90 minutes
Total2-12 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacodynamics

Pseudoephedrine releases norepinephrine,5 indirectly activating adrenergic receptors.2 This sympathomimetic action constricts blood vessels5 and can increase blood pressure,2 heart rate, and the force of heart contractions.6

Pharmacokinetics

Pseudoephedrine readily enters the brain, although its hydrophilicity favors some peripheral selectivity. It is not metabolized by monoamine oxidase (MAO).6 More acidic urine increases its excretion and reduces exposure, while more alkaline urine slows its excretion and increases exposure.

Metabolitesnone documented yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.

Full Tolerance
Tolerance develops with prolonged pseudoephedrine use, particularly when doses are taken at short intervals. The time required to develop full tolerance is not specified.

Harm Potential

Addiction & Dependence

Physical

A case report describes temporary depressive symptoms after pseudoephedrine discontinuation, including low mood, markedly reduced energy, poorer self-image, impaired concentration, psychomotor slowing, increased appetite, and increased need for sleep.

Toxicity

Lethal Dosage

Deaths involving pseudoephedrine have been reported, but a human lethal dose is not established by these findings. Toxic effects can occur at supratherapeutic doses and in people with heightened sensitivity to sympathomimetics.2

Cardiovascular

Pseudoephedrine has rarely been associated with myocardial infarction, coronary vasospasm, serious arrhythmias, and sudden death; overdose can cause circulatory collapse, chest pain, tachycardia, palpitations, and increased or decreased blood pressure.

Cerebrovascular

Pseudoephedrine has rarely been associated with hemorrhagic stroke.

Central nervous system

Pseudoephedrine overdose can cause sedation, impaired concentration, coma, tremor, and ataxia.2

Respiratory

Pseudoephedrine overdose can cause apnea and cyanosis.7

Gastrointestinal

The product information for an ibuprofen and pseudoephedrine combination lists ischemic colitis associated with pseudoephedrine hydrochloride at an unknown frequency and states that overdose may cause nausea and vomiting.7

Skin

Pseudoephedrine therapy has rarely been associated with severe skin reactions, including recurrent pseudo-scarlatina, systemic contact dermatitis, and non-pigmenting fixed drug eruption.

Urinary

Pseudoephedrine overdose can cause difficulty urinating.2

Eyes

Pseudoephedrine overdose can cause blurred vision.2

Psychosis Risk

The product information for an ibuprofen and pseudoephedrine combination lists hallucinations associated with pseudoephedrine hydrochloride at an unknown frequency and includes hallucinations among overdose symptoms.7

Seizure Risk

Low

Pseudoephedrine overdose can cause convulsions.2

History & Culture

Pseudoephedrine occurs naturally alongside ephedrine in ephedra, an herb used for thousands of years in traditional Chinese medicine.8 In 1889, the German chemists Ladenburg and Oelschlägel first isolated and characterized pseudoephedrine using a sample extracted from…

Legality

International

Pseudoephedrine is widely sold as a decongestant.

References

Citations

  1. Ephedra. The Pharmacologist, American Society for Pharmacology and Experimental Therapeutics (2025). https://thepharmacologist.org/ephedra12
  2. Pseudoephedrine—Benefits and Risks. International Journal of Molecular Sciences (2021). https://doi.org/10.3390/ijms221051461234567891011
  3. Ephedrine and Related Substances. Medicine Monographs, The Williams & Wilkins Company (1930). https://www.sciencemadness.org/library/books/ephedrine_and_related_substances.pdf1
  4. Effect of Oral Pseudoephedrine on Blood Pressure and Heart Rate: A Meta-analysis. Archives of Internal Medicine (2005). https://doi.org/10.1001/archinte.165.15.168612
  5. Pseudoephedrine Monograph for Professionals. Drugs.com / AHFS (n.d.). https://www.drugs.com/monograph/pseudoephedrine.html12
  6. In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine. Reviews in Endocrine and Metabolic Disorders (2021). https://doi.org/10.1007/s11154-021-09658-w12
  7. Sudafed Sinus Pressure & Pain 200mg/30mg film-coated tablets - Summary of Product Characteristics. electronic medicines compendium (n.d.). https://www.medicines.org.uk/emc/product/9174/smpc123
  8. Ephedra in Perspective: a Current Review. Phytotherapy Research (2003). https://doi.org/10.1002/ptr.13371
  9. Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants. Frontiers in Psychiatry (2021). https://doi.org/10.3389/fpsyt.2021.6573971
  10. Substitution of phenylephrine for pseudoephedrine as a nasal decongeststant. An illogical way to control methamphetamine abuse. British Journal of Clinical Pharmacology (2007). https://doi.org/10.1111/j.1365-2125.2006.02833.x1

Further Reading

  1. Broadley 2010 - The vascular effects of trace amines and amphetamines
  2. Rothman et al. 2003 - In Vitro Characterization of Ephedrine-Related Stereoisomers at Biogenic Amine Transporters and the Receptorome Reveals Selective Actions as Norepinephrine Transporter Substrates

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Pseudoephrine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.